The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Immunoscore®: classifying patients based on immune characteristics
Jérôme Galon
• 14 Oct 2021
Jérôme Galon, MD, PhD, Inserm, Paris, France, discusses the Immunoscore® assay, which is based on three characteristics of the cancer immune contexture: the types, the location, and the density of immune cells. Dr Galon describes how the assay is used to classify patients based on their immune characteristics. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
